Navigation Links
Common Desert Shrub may Increase Longevity

A study on mice has shown that a synthetic derivative of a common North American desert shrub, creosote, may help boost the odds of living longer.

University of Michigan scientist Richard A. Miller says that the compound derived from creosote is called NDGA.

While presenting the preliminary results of the study at the annual meeting of the American Aging Association, he said that male mice fed a normal diet and NDGA have so far been found to survive in significantly greater numbers than mice on a normal diet.

This is the first time to my knowledge when an agent has been shown to extend median life span in three laboratories, says Miller, Professor of Pathology.

He, however, conceded that no significant difference occurred in female mice, and could not explain why there was such a difference.

We dont know how NDGA is having its effect on survival in this first analysis. It may be that the female mice because of their hormonal status have other pathways to death and disability, or need higher or lower levels of NDGA to see an effect, Miller says.

Miller says that answers to the questions whether the mice fed NDGA, already well past middle age, live past the normal outer limit of old age, can be obtained only once all the mice in the control group have died in six to 10 months.

If NDGA turns out to extend maximal lifespan by 20 or 30 percent, people would accept that as an important finding, he says.

The researcher further said that much more research was needed before any possible human anti-aging drug could emerge.

Even if this agent turns out to be good for mice, it wont be possible to tell without careful studies of humans whether NDGA is beneficial, useless, or harmful to people. Occasionally, something that is harmless in mice turns out to be highly toxic for people, Miller cautioned.

He also pointed out that the Food and Dr
'"/>




Page: 1 2

Related medicine news :

1. Common contraception
2. Common Cold Remedy May Treat SARS
3. Common Plant Triggers Asthma
4. Pain Common in People with MS
5. Common Cold Found to Fight Cancer
6. Bullying – a Common Problem Among Childre
7. Common Medication Errors in Children
8. A Common Cause Of Allergy That Goes Unnoticed
9. Genetic Breakthrough in Common Eye Problem
10. Common Cold Found to Fight Cancer Cells
11. Side Effects Of Some Common Drugs
Post Your Comments:
(Date:12/1/2008)...Patient satisfaction scores at,outpatient health ... report,from Press Ganey Associates, Inc. The 20...on American Health Care cites increased competitio... patient services. The report,includes responses... than,1,200 outpatient care facilities nationwide...
(Date:12/1/2008)...e availability of a portable eight-slice computed ...ignificantly increase the number of stroke victims...Results of the study, conducted at North Shore Med... will be presented today at the annual meeting of ... , "The hospital,s acquisition of a portable CT ...
(Date:12/1/2008)...nection between second-hand smoke and coronary hea...s passed to reduce such passive smoking, exposures... January 2009 issue of the American Journal of Pr...y of California, San Francisco, Partners Healthcar...d the CHD Policy Model to better predict future tr...
(Date:12/1/2008)...en their DNA is damaged, in a process known as cel...m leading to unregulated cell division and therefo... week,s issue of PLoS Biology , has found that wh...nto their surrounding environment. This causes inf...development of age-related diseases including, iro...
Breaking Medicine News(10 mins):Health News:Outpatient Service Facilities Face Increasing Competition - Patient Perceptions More Important Than Ever 2Health News:Portable CT increases chance of stroke survival and recovery 2Health News:Escape cancer, but age sooner? The dark side of the tumor suppressing process 2
...n a major step toward cloning pigs whose hearts, l... humans. Such organs would save the lives of thous...plants because of the shortage of human organs.// ...created the sheep Dolly, scientists say they produ...
...ty during pregnancy can increase a mother's risk o...at women who were very anxious// in the last three...oural problems. Lead researcher Professor Vivette...told that this only applied to women who had extre...
...lion over-the-counter drugs each year to treat rou...more and more drugs have made the switch from pres...icans, particularly senior citizens, misuse over-t...ll. Consumers have also complained that words like...
...nts with certain drugs helps them do a better job ...have been cleared surgically. But a new report sug...rs found that stents coated with a derivative of t...ivision - failed to keep blood vessels open in the...
Other Medicine News:Health News: Pig cloning for organs, 2
(Date:12/1/2008)...AGO, Dec. 2 A study has... new technique for imaging the breast, is not affe...l status, two factors that limit the effectiveness...er. Results will be presented today at the annual ...ca (RSNA). , , "The ability of PEM to dete...
(Date:12/1/2008)...sphatasia Treated With ENB-0040 at Children,s Hosp... MONTREAL, Dec. 1 Enobia Pharma, ...veloping novel therapeutics for serious bone disor...t in its clinical program for hypophosphatasia was... Therapy (ERT) with ENB-0040 for the treatment of ...
(Date:12/1/2008)...eduled for Tuesday, December 9 at 11:00 am ET to D... SOUTH SAN FRANCISCO, Calif., Dec. 1 /PRNewswire...aq: SNSS ), a biopharmaceutical company focused ...cology therapeutics, today announced new data from...a (AML) will be presented during the 50th American...
(Date:11/28/2008)... November 28 German biotech compan...ecialized HIV monitoring and,AIDS patient follow-...es. In,the year 2008, 2.5 million patient tests h...highly affordable "CyFlow" system, supporting alre...DS. Due to introduction of the,Partec innovation,...
Breaking Medicine Technology:New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2CareAnalyzer From DST Health Solutions Helps Health Plans Improve Care Management and Quality for Members 28102 1CareAnalyzer From DST Health Solutions Helps Health Plans Improve Care Management and Quality for Members 28102 2Many Breast Cancer Patients Are Not Receiving Most Advanced Breast Conserving Surgical Techniques New Study Finds 28099 1Many Breast Cancer Patients Are Not Receiving Most Advanced Breast Conserving Surgical Techniques New Study Finds 28099 2Many Breast Cancer Patients Are Not Receiving Most Advanced Breast Conserving Surgical Techniques New Study Finds 28099 3 What Boomers Need to Know About Digestion 3B Enzymatic Therapy 26apos 3Bs CompleteGest1 Renew targets special digestive issues 28096 1 What Boomers Need to Know About Digestion 3B Enzymatic Therapy 26apos 3Bs CompleteGest1 Renew targets special digestive issues 28096 2Celebrity Cosmetic Dentist to Guest Co Host New National Day Time Talk Show 28093 1Celebrity Cosmetic Dentist to Guest Co Host New National Day Time Talk Show 28093 2
.../PRNewswire/ -- LigoCyte,Pharmaceuticals presented...with their influenza virus-like particles (VLPs),i...nge study. The,company,s data were presented by Dr...ne development, at the Tenth Annual Conference on,...ion of Infectious,Diseases in Baltimore. , The cur...
..., 2007 - Biogen Idec (NASDAQ: BIIB),and Elan Corpo...ata,from the TOUCH Prescribing Program(TM) and TYG...revious clinical studies of,TYSABRI(R) (natalizuma...he American Academy of Neurology in Boston, MA wer...s a sustained treatment,effect on clinical relapse...
Other Medicine Technology:LigoCyte Pharmaceuticals Presents Data Showing Heterosubtypic,Protection Against Influenza Challenge With Virus-Like Particle,Immunization 2Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 2Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 3Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 4Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 5Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 6
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: